Detailed answers about UK REID PHARMACEUTICAL HOLDING LTD, including incorporation, status, business activity, and accounts information.
When was UK REID PHARMACEUTICAL HOLDING LTD founded?
UK REID PHARMACEUTICAL HOLDING LTD was officially incorporated on 8 March 2023 and is registered under company number 14714538. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is UK REID PHARMACEUTICAL HOLDING LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of UK REID PHARMACEUTICAL HOLDING LTD?
UK REID PHARMACEUTICAL HOLDING LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does UK REID PHARMACEUTICAL HOLDING LTD do?
UK REID PHARMACEUTICAL HOLDING LTD operates in the following sectors: 46190 - Agents involved in the sale of a variety of goods, 46460 - Wholesale of pharmaceutical goods, 46900 - Non-specialised wholesale trade, 82990 - Other business support service activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is UK REID PHARMACEUTICAL HOLDING LTD's registered address?
The registered office address of UK REID PHARMACEUTICAL HOLDING LTD is 61 BRIDGE STREET, KINGTON, HEREFORDSHIRE, HR5 3DJ. This is the official address filed with Companies House for legal and statutory correspondence.
Is UK REID PHARMACEUTICAL HOLDING LTD financially stable?
The most recent accounts for UK REID PHARMACEUTICAL HOLDING LTD were made up to 31 March 2025, filed as DORMANT. Next accounts are due by 31 December 2026.